• Behavioral Health
  • Clinical Insights
  • Treatment

March 2024 drug trend report

Mar 13th, 2024

Staying on top of new drug launches and shortages can be difficult. Read Genoa Healthcare’s latest drug trend report for an overview and connect with your local pharmacy team to learn more.

Brand name drug launches*

Uzedy

  • Indicated for: Treatment of schizophrenia in adults
  • Dosage form: Long-acting injectable administered subcutaneously in the abdomen or upper arm.
  • Status: Available now

For more information on the new treatment option for adults living with schizophrenia, read the Uzedy™ blog post here.

Generic drug launches*

Pradaxa (dabigatran etexilate mesylate)

  • Indicated for: Treatment of nonvalvular partial fibrillation and venous thromboembolism
  • Dosage form: Capsules
  • Status: Available now

Top drug shortages*

Naltrexone

  • Indicated for: Treatment of alcohol and/or opioid use disorder
  • Status: Recovery TBD

Trulicity

  • Indicated for: Treatment of type 2 diabetes
  • Status: Recovery TBD

Paliperidone

  • Indicated for: Treatment of schizophrenia and schizoaffective disorder
  • Status: Recovery TBD

*Information on this page was accurate at the time of posting. Shortage recovery dates are only estimates. These estimates are based on the distribution information that Genoa has access to.

Recent Posts


  • Partnering with Genoa
  • People-first Pharmacy Care
In-house, pharmacy management partnership or outsource? Questions to ask before choosing an on-site pharmacy model

Want to compare your options quickly? Download this overview. You’ve probably heard the benefits of adding a pharmacist to your care team. On-site pharmacies help break down barriers to care,...

  • 340B
340B made easy: 5 traits to look for in a contract pharmacy partner

The 340B Drug Pricing Program helps participating organizations – or covered entities – use savings on prescription drug costs to offer more comprehensive services and care for more eligible patients....

  • Behavioral Health
  • Clinical Insights
  • Treatment
Quick guide to recently approved behavioral health medications

Keeping up with new and emerging treatment options for your consumers can be difficult. Genoa Healthcare’s Tim Krause, PharmD, compiled a quick guide to share the latest on recently approved...

  • Clinical Insights
  • Treatment
Long-acting injectables in practice: What providers need to know

Genoa Healthcare recently hosted a webinar where Senior Product Manager Blake Shoemaker, PharmD, discussed long-acting injectables (LAIs) in practice. Watch the recording below for an overview on benefits, challenges and...